Australians trial Botox to treat hay fever

The best-selling wrinkle erasing drug Botox will be used in an Australian study to treat hay fever, researchers said Tuesday after it showed promise in providing relief in early trials.

Philip Bardin, a professor at the Monash Medical Centre which is linked to Melbourne's Monash University, said Botox was already widely used in medicine to reduce spasms in muscles following strokes and in treating cerebral palsy.

"This is very new way to use an old medication," he said.

Under the trial, a Botox gel will be applied to the nose to hopefully give hay fever sufferers relief from sneezing, itchy eyes and runny noses for up to three months.

"Part of why this is possible is that the Botox molecule has been re-engineered to be able to penetrate through the skin but also through the lining of the nose," Bardin told AFP.

"That's really the crucial development that has taken place. So consequently it is going to be possible in the future to extend its use from being mostly a cosmetic product... to become possibly even more useful."

In treating hay fever, the will affect the nerves in the nose and potentially block some of the chemicals released by the which play a large role in causing symptoms, he said.

Seventy people will be recruited for the study following a preliminary trial that suggested the drug provided relief.

Botox, which makes muscles relax, is a purified form of a produced by a bacteria that causes a disease which paralyses muscles and can be fatal.

It was first used to treat disorders of the —uncontrollable blinking and misaligned eyes.

Its cosmetic use took off in the 1990s after a Canadian noticed her patients were losing their frown lines after using the medication.

add to favorites email to friend print save as pdf

Related Stories

Botox developer rues missing out on billions

Feb 13, 2012

Botox developer Alan Scott says he rues the day he handed over rights to the best-selling wrinkle-smoothing drug to a US company for just $4.5 million, saying he might have become a billionaire.

Botox to iron out Australian asthma wrinkles

Jun 28, 2011

It is more celebrity than respiratory, but botox could prove a breath of fresh air for asthmatics if an Australian trial of the toxin launched Tuesday is successful.

Study questions botox use for migraines

Feb 08, 2011

The anti-wrinkle drug Botox, which has been licensed in some countries as a treatment for chronic migraine, has negligible effect against these headaches, a study published on Tuesday said.

US approves Botox for bladder control

Aug 24, 2011

The face-freezing pharmaceutical injection Botox gained another medical use on Wednesday when the US government approved it for use in some patients with overactive bladder.

Dysport the newest wrinkle-stopping drug to hit market

May 13, 2009

There's a new wrinkle remover on the market. Late last month, the U.S. Food and Drug Administration sanctioned Dysport for cosmetic and therapeutic use. Like Botox, it's an injectable drug derived from a botulinum toxin. ...

Recommended for you

Evidence-based recs issued for systemic care in psoriasis

18 hours ago

(HealthDay)—For appropriately selected patients with psoriasis, combining biologics with other systemic treatments, including phototherapy, oral medications, or other biologic, may result in greater efficacy ...

Bacteria in caramel apples kills at least four in US

18 hours ago

A listeria outbreak believed to originate from commercially packaged caramel apples has killed at least four people in the United States and sickened 28 people since November, officials said Friday.

Steroid-based treatment may answer needs of pediatric EoE patients

18 hours ago

A new formulation of oral budesonide suspension, a steroid-based treatment, is safe and effective in treating pediatric patients with eosinophilic esophagitis (EoE), according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal ...

Discovery of genes that predispose a severe form of COPD

21 hours ago

A study by Ramcés Falfán-Valencia, researcher at the National Institute of Respiratory Diseases (INER), found that the mestizo Mexican population has a number of variations in certain genes that predispose ...

On the environmental trail of food pathogens

22 hours ago

Tracking one of the deadliest food contamination organisms through produce farms and natural environments alike, Cornell microbiologists are showing how to use big datasets to predict where the next outbreak could start.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.